SEC Form 4 · accession 0001253497-26-000005
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Glenn
Officer — CFO
Period of report
Jun 20, 2026
Accepted (ET)
Jun 23, 2026 · 9:29 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 20, 2026 | M | 5,796 | — | A | 14,256 | D | |
| Common Stock | Jun 20, 2026 | F | 2,319 | $92.20 | D | 11,937 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 20, 2026 | M | 5,796 | D | — | — | Common Stock | 5,796 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
- F2The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 30, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.